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Abstract
Background: The genetic regulation of metabolic phenotypes (i.e., metabotypes) in type 2 diabetes mellitus occurs
through complex organ-specific cellular mechanisms and networks contributing to impaired insulin secretion and
insulin resistance. Genome-wide gene expression profiling systems can dissect the genetic contributions to
metabolome and transcriptome regulations. The integrative analysis of multiple gene expression traits and metabolic
phenotypes (i.e., metabotypes) together with their underlying genetic regulation remains a challenge. Here, we
introduce a systems genetics approach based on the topological analysis of a combined molecular network made of
genes and metabolites identified through expression and metabotype quantitative trait locus mapping (i.e., eQTL and
mQTL) to prioritise biological characterisation of candidate genes and traits.
Methods: We used systematic metabotyping by 1H NMR spectroscopy and genome-wide gene expression in white
adipose tissue to map molecular phenotypes to genomic blocks associated with obesity and insulin secretion in a series
of rat congenic strains derived from spontaneously diabetic Goto-Kakizaki (GK) and normoglycemic Brown-Norway (BN)
rats. We implemented a network biology strategy approach to visualize the shortest paths between metabolites and
genes significantly associated with each genomic block.
Results: Despite strong genomic similarities (95–99 %) among congenics, each strain exhibited specific patterns of
gene expression and metabotypes, reflecting the metabolic consequences of series of linked genetic polymorphisms in
the congenic intervals. We subsequently used the congenic panel to map quantitative trait loci underlying specific
mQTLs and genome-wide eQTLs. Variation in key metabolites like glucose, succinate, lactate, or 3-hydroxybutyrate and
second messenger precursors like inositol was associated with several independent genomic intervals, indicating
functional redundancy in these regions. To navigate through the complexity of these association networks we mapped
candidate genes and metabolites onto metabolic pathways and implemented a shortest path strategy to highlight
potential mechanistic links between metabolites and transcripts at colocalized mQTLs and eQTLs. Minimizing the
shortest path length drove prioritization of biological validations by gene silencing.
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Conclusions: These results underline the importance of network-based integration of multilevel systems genetics
datasets to improve understanding of the genetic architecture of metabotype and transcriptomic regulation and to
characterize novel functional roles for genes determining tissue-specific metabolism.
Keywords: 1H NMR, Metabolomics, Transcriptomics, Genome Mapping, mQTL, eQTL, Metabolic networks
Background
Type 2 diabetes mellitus is a prime example of a multifac-
torial disease, combining genetic risk factors and environ-
mental influences, including the gut microbiome [1].
Complexity in diabetes etiology and pathogenesis relates to
the existence of numerous risk genes, which often lack clear
biological roles and have small effects on relevant disease
traits [2–8], and the contribution of organ-specific cellular
mechanisms to hyperglycemia and complications through
impaired insulin secretion in pancreatic β cells and insulin
resistance in central and peripheral tissues [9, 10]. Although
genome-wide association studies (GWAS) have identified
many diabetes risk variants [6, 7, 11–13], the underlying
mechanisms remain elusive. Functional annotation of
disease risk loci can progress with advances in high-density
molecular phenotyping approaches, mainly transcriptomics
[14–17] and metabonomics [11, 18], which inform about
gene and metabolite networks for various tissues.
Combining these high-throughput technologies generates
complementary, and potentially convergent, multidimen-
sional information on the function of the genome and
individual genes.
Metabolic phenotyping (i.e., metabotyping) [19, 20] re-
lates to quantitative physiological and biochemical changes
to both phenotypic and genetic variation. Metabotypes
provide a read-out for gene–environment interactions in-
cluding microbiome influences [21, 22]. Metabotyping is
particularly appropriate to define biomarkers associated
with diabetes risk [9, 11, 23]. In previous studies, we and
others have demonstrated genome mapping of 1H NMR
quantitative metabotypes in mouse and rat genetic crosses
and defined causal relationships between segregating gen-
etic polymorphisms and variations in metabolite abun-
dance [18, 24–28]. Implementation of this strategy in
humans remains limited to genetic associations in blood
[29–33] and urine [9, 32, 34] but will most likely progress
with genetic analysis of metabolic regulation in many or-
gans from many individuals [35, 36]. Meanwhile, rodent
models of complex disorders represent useful systems to
investigate the direct molecular consequences of naturally
occurring genetic polymorphisms and to understand the
genetic architecture of metabolic regulation in biofluids
[18, 26, 37] and organs [38–40].
The integrative analysis of expression quantitative trait
loci (eQTL)-associated gene networks [15, 41] and metabo-
lomic quantitative trait loci (mQTL)-associated metabolite
and candidate gene networks remains a challenge [2, 42].
Here, we present an integrative systems genetics approach
designed to identify mechanistic relationships between
linked alleles in genomic blocks and metabolism using 1H
NMR-based metabotyping combined with genome-wide
transcriptomic analyses. In a previous study we identified
QTLs for adiposity (retroperitoneal fat pad weight) and in-
sulin secretion on chromosome 1 [9, 43], which enabled
the congenic breeding program to confirm the original as-
sociations [11, 39]. We selected a series of 12 congenic
strains carrying contiguous regions of various lengths (1–
177 Mb) of chromosome 1 of the spontaneously diabetic
(type 2) Goto-Kakizaki (GK) rat transferred onto the gen-
omic background of normoglycemic Brown-Norway (BN)
rats for metabolic and gene expression profiling in adipose
tissue. We then carried out a joint eQTL and mQTL ana-
lysis and mapped the associated genes and metabolites
onto metabolic networks. Through topological analysis, we
implemented a parsimonious approach (i.e., Occam’s razor)
by minimizing shortest paths across the resulting networks
to identify pairs of mechanistically connected eQTL-
associated genes and mQTL-associated metabolites for
rapid validation in cell-based assays. Our approach
indicates that distinct blocks of genetic polymorphisms dif-
ferentially impact the adipose tissue metabolic network,
thereby prioritizing candidates for gene silencing in
adipocytes, exemplified by Galm and Asns.
Methods
Animals
A colony of GK/Ox rats bred locally and derived in 1995
from the GK/Par colony was used to produce the con-
genic strains. BN rats were obtained from a commercial
supplier (Charles River Laboratories, Margate, UK). All
congenics were derived from these strains using a genetic
marker-assisted breeding strategy (“speed congenics”) as
previously described [11, 44] and maintained by brother–
sister mating. They were specifically designed to contain
GK alleles over genomic regions of various lengths (1–
176 Mb) of rat chromosome 1, introgressed onto the gen-
etic background of the BN strain (Table 1, Fig. 1). The tar-
geted GK genomic intervals between markers D1Rat27
(90.3 Mb) and D1Got254 (264.37 Mb) cover several car-
diometabolic disease (CMD) -relevant QTLs originally
mapped in F2 (GKxBN) genetic crosses [9, 45, 46]. GK al-
leles on the X chromosome were lost early in the breeding
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program by two consecutive breedings of male backcross
animals to BN females. All animals used in this study were
systematically genotyped with markers chosen to accur-
ately monitor retention of GK alleles across the congenic
intervals and absence of GK allele contaminants from the
genetic background [47, 48]. All strains were co-housed in
order to avoid cage-specific microbiome selection [14, 49].
Rats were allowed free access to tap water and
standard laboratory chow pellets (B&K Universal Ltd,
Grimston, Aldbrough, Hull, UK) and were maintained
on a 12-h light–dark cycle. All rats were identified using
a microchip (identity chip, Animal Care Ltd, York, UK)
linked to a database specifically designed to administer
the project (husbandry, phenotype scheduling, and data
Table 1 Genomic details of the BN.GK congenic strains
Congenic name Last marker BN allele First marker GK allele Last marker GK allele First marker BN allele Genomic length (Mb)
1cns D1Got96 (88.6) D1Rat27 (90.3) D1Got353 (266.9) - (Telomere) 176.6–179.3
1b D1Rat77 (238.0) D1Got237 (246.7) D1Got353 (266.9) - (Telomere) 20.2–29.9
1d J576143 (225.8) J337594 (227.9) D1Got231 (231.6) D1Got224 (233.0) 3.7–7.2
1f J576143 (225.8) J337594 (227.9) D1Got353 (266.9) - (Telomere) 39.0–42.1
1h D1Got337 (193.5) D1Got338 (197.0) D1Rat84 (259.3) D1Cebr4 (263.8) 62.34–70.3
1k D1Got231 (231.6) Glis3 (231.9) XM_219778 (233.1) Fxna (233.3) 1.2–1.7
1o D1Got96 (90.3) D1Got100 (92.1) D1Wox86 (224.7) J576143 (225.8) 132.6–137.2
1p D1Got96 (88.6) D1Rat27 (90.3) D1Smu5 (189.5) D1Got172 (191.7) 99.2–103.1
1q D1Wox86 (224.7) J576143 (225.8) D1Rat75 (235.1) D1Wox89 (236.5) 9.3–11.8
1t J576143 (225.8) J337594 (227.9) D1Rat223 (228.8) D1Rat76 (230.4) 0.9–4.6
1u D1Wox7 (139.0) D1Wox78 (143.8) D1Got191 (175.4) D1Got326 (176.6) 31.6–37.6
1v D1Wox18 (94.6) D1Got307 (102.5) D1Got108 (127.4) D1Got318 (130.1) 24.9–35.5
Name and genomic position (Mb) of the genetic markers flanking the GK congenic intervals are given, along with the minimum and maximum genomic length
(Mb) of the introgressed GK genomic segment. Genomic positions were taken from the rat reference genome assembly (RGSC3.4, Ensembl release 69)
Fig. 1 Phenotypic features of the congenic strains. Association for body weight (a), adiposity index (b), QTL for adiposity index (c), association for
cumulative plasma glucose (d), and insulin (e) during the intravenous glucose tolerance and insulin secretion tests were measured in male rats. Solid
bars represent the GK genomic segments of chromosome 1 of each congenic strain introgressed onto the genetic background of the BN strain. The
y-axis shows genomic length (Mb) and boundaries of the genomic region of GK origin. The location of the adipose tissue QTL mapped to
chromosome 1 in the GK × BN F2 cross [9] is reported with significance threshold shown with a dashed line (c). Details of GK chromosomal regions
introgressed in each congenic strain are given in Table 1. Significantly (P < 0.05) increased and decreased values of the phenotypes between congenic
strains and the BN control are indicated in red and green, respectively. Phenotype data are available in Additional file 1: Table S1
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storage) and store genetic information and phentoypic
data [48, 50].
Phenotype analysis
Three-month-old male congenic rats and BN controls were
used for all experiments. Intravenous glucose tolerance and
insulin secretion tests (IVGTTs) were performed following
procedures strictly identical to those consistently applied in
both F2 (GK× BN) hybrids [9, 20], which we used to map
diabetes QTLs in the GK, and BN.GK congenic strains de-
rived for several GK QTLs [11, 22, 51–54]. Briefly, rats in
the post-absorptive state at the end of the post-prandial gly-
cemic response (4.5 to 5 h fasting from 9–9:30 am when
food was removed until 2 pm when the IVGTT procedures
were initiated) were anesthetized by injection of 95 mg/kg
body weight intraperitoneal ketamine hydrochloride (Keta-
lar, Parke-Davies, UK). Rats were injected with a solution of
0.8 g glucose/kg body weight via the saphenous vein. Blood
samples were collected into heparinized tubes before glu-
cose injection and 5, 10, 15, 20, and 30 min afterward.
Plasma was separated by centrifugation prior to glucose as-
says using a diagnostic kit (ABX, Shefford, UK) on a Cobas
Mira Plus automatic analyzer (ABX, Shefford, UK) and
assay of immunoreactive insulin (IRI) using an ELISA kit
(Mercodia, Uppsala, Sweden). Cumulative values of plasma
glucose and plasma insulin during the IVGTTs were calcu-
lated to evaluate overall glucose tolerance and insulin secre-
tion capacity in response to glucose, respectively. At
6 months, rats were killed by terminal anesthesia following
an overnight fast (16–18 h). Retroperitoneal fat pads (RFPs)
were collected, weighed, snap frozen in liquid nitrogen, and
stored at −80 °C until preparation of tissue extracts and
RNA for analysis of the metabolome and the transcriptome,
respectively. The adiposity index was calculated as the ratio
between RFP weight and body weight.
Metabotyping of white adipose tissue by 1H NMR
spectroscopy
Tissues samples (30–50 mg) were weighed into 2-mL
Eppendorf tubes and were each homogenized in 1.5 ml
50 % methanol using TissueLyser (5 min at 25 Hz; QIA-
GEN, Germany). The mixtures were each transferred
into 3-mL glass tubes and 0.7 mL chloroform was added
into each sample. The mixtures were vortexed for 1 min
followed by centrifugation at ~3500 g for 25 min at 10 °
C. The aqueous phase was decanted and the methanol
was removed under a fume cupboard before freeze dry-
ing. The lipid phase was pipetted out and chloroform
was removed under a fume cupboard. Dried extracts
were reconstituted using 500 μL of 0.1 M phosphate
buffer solution (10 % 2H2O/H2O v/v, with 0.05 %
sodium 3-trimethylsilyl-(2,2,3,3-2H4)-1-propionate for
chemical shift reference at δ0.0) in 5-mm tubes for
NMR acquisition. Standard 1H NMR spectra were
measured on a Bruker spectrometer (Rheinstetten,
Germany) operating at 600.22 MHz 1H frequency, as
described previously [18, 55]. The 1H NMR spectra were
imported into Matlab and phase- and baseline-corrected
at high resolution. The region δ5.0–4.5 was removed to
eliminate baseline effects of imperfect water signal pre-
saturation. Each spectrum was normalized to a constant
intensity sum and each variable was mean centered.
Analyses were carried out using R and Matlab.
Orthogonal partial least squares discriminant analysis
The method allows enhanced focus on strain and diet
intervention while minimizing other biological/analytical
variation. Sample classes were modeled using the orthog-
onal partial least squares (O-PLS) algorithm. This algo-
rithm derives from the partial least squares (PLS)
regression method. In linkage analysis version, the model
explains the maximum separation between genotypes Y
(coded as 0, 1, 2 for GK allele numbers) using the NMR
data X. Further details on standard O-PLS implementa-
tion in metabonomics have been given previously [56, 57].
The model coefficients locate the NMR signals signifi-
cantly associated with genotypic variation in a specific
genomic region Y.
RNA preparation and Illumina bead array hybridization
Total RNA was individually isolated from 100 mg of RFP
(four biological replicates per strain) using the RNeasy® 96
Universal Tissue kit (Qiagen, Crawley, UK): frozen tissue
samples were transferred into cooled RNeasy® 96 Universal
Tissue plates and homogenized in QIAzol Lysis Reagent
using a Qiagen Tissue Lyser. Following phase separation
after addition of chloroform, total RNA was purified with
RNeasy columns using a spin technology according to the
manufacturer’s guidelines and eluted in RNase-free water.
RNA concentrations were determined using a NanoDrop
spectrophotometer and RNA quality, purity, and integrity
were assessed using an Agilent 2100 Bioanalyser (Agilent
Technologies, Waldbronn, Germany).
Samples were independently used to hybridize Gene Ex-
pression Sentrix® BeadChip RatRef-12 v1 arrays (Illumina
Inc., San Diego, CA, USA) containing 22,523 oligonucleo-
tide probes (replicated 30 times on average). They allowed
interrogation of transcript levels for 21,910 genes (6274
RefSeq NM transcripts, 15,983 Refseq XM transcripts, 12
Refseq XR transcripts, 250 Unigene clusters). Double-
stranded cDNA and purified biotin-labeled cRNA were
synthesized from 300 ng high quality total RNA using the
Illumina® TotalPrep RNA Amplification Kit (Ambion Inc.,
Austin, TX, USA). cRNA concentrations were determined
using a NanoDrop spectrophotometer whilst cRNA quality
and integrity were assessed using an Agilent 2100 Bioana-
lyser (Agilent Technologies, Waldbronn, Germany).
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Hybridizations onto the arrays were carried out using
750 ng of each (132) biotinylated cRNA in a 58 °C
hybridization oven for 18 h. Following washing and stain-
ing with Streptavidin-Cy3, the BeadChip Arrays were
scanned on the Illumia® BeadArray Reader (Illumina Inc.,
San Diego, CA, USA). Resulting data were then preliminar-
ily analyzed using the Illumina® BeadStudio Application
software before undergoing comprehensive statistical ana-
lysis. Particular attention was given to the following quality
control parameters: 0 ≤G sat ≤ 1; Green 95 percentile
(GP95) for consistency between arrays (around 2000); GP5
background level in the range of the low 100 s or below.
Microarray experiments were compliant with MIAME
(Minimum Information About a Microarray Experiment)
and both protocol details and raw data have been depos-
ited in ArrayExpress (http://www.ebi.ac.uk/arrayexpress/)
under accession number E-MTAB-1048.
Network representation of genome–metabolome
associations
In order to explore genome–metabolome associations, a
functional association network was derived from metabo-
type and genotype correlation coefficients using the
bipartite graph Rgraphsviz package from R to represent the
O-PLS correlation matrix derived from the linkage analysis
between NMR variables and genotypes. A cutoff was then
applied to the P value of the Pearson’s correlation coeffi-
cient adjusted using Benjamini and Hochberg’s multiple
testing correction (PBHadj < 0.05); significant correlations
were set to 1 and non-significant correlations were set to 0,
defining the adjacency matrix for the graph. Hence, G = (N,
E) specifies a graph G with N denoting the two node sets
(two types of nodes: genomic regions and metabolites) and
E the edge set (link between nodes, here a correlation
between metabotypes and genotypes above the cutoff, i.e.,
PBHadj < 0.05).
Integration of eQTL-responsive genes and mQTL-
responsive metabolites on KEGG metabolic networks to
identify functional candidates
Differentially regulated genes and metabolites that could be
associated with GK haplotypes were mapped to KEGG
pathways. Metabolic pathways were imported in R using
KEGGgraph [55, 58]. An in-house python script was writ-
ten to generate an adjacency table. The resulting region-
specific networks were mathematically formalized as a di-
rected multilabeled graph Gm,n = (Vm,E) composed of two
types of nodes Vm, where m= (“metabolic reactions”, “me-
tabolites”), and functional equally-weighted edges corre-
sponding to network connectivity (i.e., metabolic reactions)
between enzymes and metabolites. To identify pairs of
eQTL-associated genes coding for enzymes that are meta-
bolically connected with mQTL-associated metabolites, we
computed shortest paths from the eQTL genes mapped on
the KEGG network to the target mQTL metabolites using
the igraph R package. Defining shortest path lengths (spl)
corresponds to counting the minimal number of additional
reactions required to connect a given gene and a given me-
tabolite across the metabolic network. For example, Galm
and β-D-glucose have a spl of 0 as β -D-glucose is the prod-
uct of the reaction catalyzed by Galm (rn:R01602). The
gene Asns is annotated as AsnsA and AsnsB since it in-
volves two catalytic sites for two different reactions
(rn:R00256 for AsnsB and rn:R00578 for AsnsA).
shRNA-based inhibition of Galm and Asns expression in
vitro in 3T3-L1 cells
3T3-L1 fibroblasts (ATCC, Molsheim, France) were cul-
tured in 10 % calf serum (PAA, Velizy, France) containing
DMEM high glucose (Life Technologies, Saint Aubin,
France). Cells were plated at 105 cells/well density until
confluence and differentiated into adipocytes in 10 % fetal
bovine serum (FBS; Life Technologies, Saint Aubin,
France) containing DMEM high glucose, IBMX, dexa-
methasone (Sigma-Aldrich, Saint-Quentin, France), and
insulin. Differentiated 3T3-L1 cells were maintained in
5 % FBS and DMEM high glucose.
We used pGFP-V-RS-shRNA plasmids (Origene, Rock-
ville, MD, USA) containing short hairpin RNA (shRNA) se-
quences specifically designed to target Asns or Galm and a
puromycin resistance gene cloned between integrative long
terminal repeat sequences. The Platinum-Ecotropic Retro-
viral Packaging Cell Line (Cell Biolabs, San Diego, CA,
USA) producing host range recombinant γ-retroviruses
was used for shRNA-containing viral production. Platinum
E cells were maintained in DMEM supplemented with glu-
cose and 10 % FBS, puromycin, and blasticidin (Sigma-Al-
drich, Saint-Quentin, France). Transfection was performed
after adapting culture medium for 3T3-L1 cells (DMEM
high glucose and 10 % calf serum without antibiotics).
Fugene 6 HD® (Roche, Boulogne, France) was used accord-
ing to the manufacturer’s recommendation in 3T3-L1
medium. Plasmid transfection efficiency was determined by
GFP fluorescence. Supernatants were collected 48 h after
transfection to transduce 3T3-L1 in the presence of poly-
brene (Sigma-Aldrich, Saint-Quentin, France). Puromycin
selection started 24 h post-transduction.
Differentiation and glucose transport in shRNA-transfected
3T3-L1 adipocytes
For differentiation analysis, cells were first incubated in
10 % formaldehyde (Sigma-Aldrich, Saint-Quentin, France),
washed with 60 % isopropanol, and dried. A solution Oil
Red O (Sigma-Aldrich, Saint-Quentin, France) was added
and dishes were washed with distilled water. Quantification
of coloration was performed by spectrophotometry at
490 nm with a plate reader (Perkin Elmer, Villebon, France).
A separate batch of cells was used for glucose transport
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analysis, which was determined by incubation with a solu-
tion containing 0.5 μCi tritium labeled 2-deoxy-D-glucose.
Briefly, adipocytes were cultured in DMEM high glucose
without FBS for 4 h and washed with a buffer containing
CaCl2, MgCl2, fatty acid free BSA (PAA, Velizy, France) in
PBS (Life Technologies, Saint Aubin, France), followed by
20 min of insulin stimulation (100 nM). After 10 min of in-
cubation with labeled 2-deoxy-D-glucose, cells were washed
in ice-cold PBS and collected in a solution of NaOH for
radioactivity recording and protein content quantification.
Results
Pathophysiological features of the congenic series
To attach specific patterns of diabetes intermediate phe-
notypes to each BN.GK congenic strain used in the
study (Table 1) glucose tolerance, in vivo insulin secre-
tion, body weight, and adiposity index were determined
for each animal at 3 months. Rats from different strains
were co-housed in the same cage to avoid cage-specific
microbiome selection [14, 17, 59]. As previously ob-
served [11], the strain carrying the largest GK haplotype
(179.3 Mb in BN.GK1cns) exhibited increased body
weight (270.0 ± 5.7 versus 243.4 ± 3.5) and adiposity
(0.416 ± 0.028 versus 0.376 ± 0.031), glucose intolerance
(CumG, 5504 ± 135 versus 5104 ± 83) and enhanced
glucose-induced insulin secretion (CumI, 70.21 ± 11.50
versus 43.45 ± 3.23). To dissect the genetic basis of body
weight and glucose homeostasis on chromosome 1, we
validated these phenotypes in congenic substrains con-
taining smaller GK genomic blocks introgressed into the
BN normoglycemic genome (Fig. 1). Validation was
achieved in nine congenic strains, which exhibited sig-
nificant changes in body weight (Fig. 1a; BN.GK1f, 1k,
1o, 1p, 1t, 1u) and adiposity (Fig. 1b; BN.GK1p, 1u)
when compared to BN (Additional file 1: Table S1). Rats
of congenic strains BN.GK1cns, 1p and 1u showed con-
sistent increases in both body weight and adiposity
index, suggesting coordinated regulation of these pheno-
types by common genetic polymorphisms in the shared
GK genomic region (143.8–175.4 Mb) of rat chromo-
some 1 corresponding to a region of significant linkage
to adiposity in the GK × BN F2 cross (Fig. 1c). Impaired
glucose tolerance in BN.GK1o (Fig. 1d) may be the
consequence of impaired insulin secretion (Fig. 1e),
whereas improved glucose tolerance in BN.GK1h and
1q may be caused by enhanced insulin response to
glucose (Fig. 1d, e). Rats of strains BN.GK1d and 1v
did not show any significant change in any of these
parameters when compared to BN controls (Fig. 1;
Additional file 1: Table S1).
These data underline the strong phenotypic hetero-
geneity in these congenic strains and the complexity of
the underlying genetic regulation, even though they
share 95–99 % genomic homology with the BN control.
Strain-specific phenotypic features can be attached to
GK genomic blocks contained in each congenic line and
therefore characterize the systems-wide effects of linked
GK genetic polymorphisms in each contiguous region of
chromosome 1.
1H NMR-based metabotyping of adipose tissue in con-
genic strains
To complement pathophysiological phenotypes in the
congenics with molecular phenotypes, and to investigate
possible relationships between physiological and metabolic
variables, we carried out 1H NMR metabotyping of aque-
ous extracts of white adipose tissue from rats of the 12
BN.GK congenic strains and the BN control (Additional
file 2: Figure S1). A total of 34 metabolites were detected,
31 of which could be assigned using published data [9, 19,
46] and in-house databases (Table 2). We then built or-
thogonal partial least squares discriminant analysis (O-
PLS-DA) models to compare metabolite patterns in
each congenic strain to the BN normoglycemic control
(Additional file 2: Figure S2). The robustness of each
O-PLS model was tested by sevenfold cross-validation
and resampling under the null hypothesis as described
previously [21, 48]. The range of distribution of the Q2Y
values (0.35–0.88) for each of the congenic models sug-
gests the presence of a clear discrimination of congenic
lines (Additional file 1: Table S2). We identified 19 metab-
olites exhibiting variations in abundance between at least
one congenic strain and the BN control (Additional file 2:
Figure S3; Table 2).
Definition of strain-specific metabotypes in the congenic
series
To simultaneously visualize all metabotypes characterizing
each congenic strain, we constructed a binary association
map summarizing strain–metabolite associations (Fig. 2a;
Additional file 2: Figures S2 and S3). The congenic strains
BN.GK1b and 1u exhibited differential regulation of many
metabolites when compared to BN. Only a few metabo-
lites showed a strain-specific pattern of regulation, such as
succinate in GK1b and taurine and glycerol in BN.GK1u.
In contrast, several metabolites were differentially regu-
lated in many congenic strains (e.g., N-acetylglutamine, L-
glutamate, glycerophosphocholine, scyllo-inositol, inosine;
Fig. 2a), suggesting consistent effects of common genetic
polymorphisms in the shared GK genomic blocks in these
strains. For example, inosine, which is consistently more
abundant in BN.GK1d, 1h and 1q, may be controlled by a
gene in the GK genomic block of BN.GK1d (225.8–
233.0 Mb), whereas scyllo-inositol (δ3.36, s) was downreg-
ulated in three congenic strains (BN.GK1b, 1q, 1u) that
carry distinct GK genomic blocks and is therefore con-
trolled by different genes. Discordant trends of metabolic
regulation among congenics were found for N-acetyl
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glutamine and L-glutamate, which were more abundant in
adipose tissue of BN.GK1b, 1f, 1k, 1cns, 1p, 1q, 1t, and 1u
than in the BN control and showed an opposite trend of
regulation in BN.GK1q. These results illustrate the exist-
ence of genetically determined metabotypes and suggest
functional redundancy in the regulation of individual
metabolites by distinct genes.
Identification of genetically determined metabotypes by
mQTL mapping
To connect genomic information with metabolic end-
points, we took advantage of the genetic structure of the
congenic panel, which is characterized by overlapping and
unique GK genomic blocks across a large region of rat
chromosome 1, to perform QTL analysis. The resulting
association networks defined 15 independent contiguous
genomic regions of GK origin across the rat chromosome
1 (Fig. 2b; Additional file 2: Figures S3 and S4). Genomic
regions R15 and R16, which cover 18 Mb and 7 Mb, re-
spectively, at the telomeric end of chromosome 1, were
often associated with a similar set of metabolites (choline,
L-glutamine, succinate, L-glutamate, acetate, L-alanine,
myo-inositol; Fig. 2b). Several metabolites (L-glutamine,
taurine, scyllo-inositol, D-glucose, L-lactate, inosine, for-
mate) were associated with several genomic regions, sug-
gesting the involvement of multiple independent GK
variants, whereas glycerophosphocholine was specifically
linked to region R5, indicating a specific effect of GK vari-
ants in this region.
Identification of genetically determined expression traits
by eQTL mapping
To test the existence of functional relationships between
metabolic changes mapped to congenic regions and gene
expression, we next carried out genome-wide transcriptome
analyses of white adipose tissue from rats of the entire con-
genic panel and from BN and GK controls. As previously
applied to metabotypes in congenic series, we performed
eQTL mapping to anchor specific gene expression patterns
to each of the 15 regions of rat chromosome 1 defined by
GK genomic blocks introgressed in the congenics. We
found evidence of genetic linkage (LOD >5) between quan-
titative variation of 378 transcripts and regions of chromo-
some 1 (Fig. 3; Additional file 1: Table S3). Over 25 % of
eQTLs correspond to genes localized within the GK gen-
omic regions in congenics, which may underlie cis-medi-
ated regulatory mechanisms. The remaining 287 eQTLs
were related to transcripts localized outside the congenic
region, which unambiguously underlie distant regulatory
mechanisms of transcription (i.e., trans-acting eQTLs, as il-
lustrated in Fig. 3).
These transcriptome data demonstrate the effect of
GK variants in the congenic intervals on genome-
wide gene expression and identify potential positional
candidate genes that may be functionally related to
changes in metabolite abundance and disease
phenotypes.
Table 2 Summary of metabolites detected in 1H NMR spectra
from adipose tissue extracts of congenic rats and BN controls
Metabolite 1H chemical shift (δ, ppm) and multiplicity
Formate 8.46 (s)
Inosinea 8.34 (s), 8.23 (s), 6.1 (d), 4.44 (t)
Non-assigned 8.27 (s)
Non-assigneda 7.68 (s)
Inosine-diphosphate 6.16 (s)
Allantoina 5.4 (s)
Lipids (C[H2]-CH2-CO) 5.31 (m)
Glucosea 5.23 (m), 3.84
Glycerophosphocholinea 4.32 (m), 3.23 (s)
Lactatea 4.11 (q), 1.33 (d)
Myo-inositol 4.06 (t), 3.61 (dd), 3.52 (dd)
Creatine 3.93 (s), 3.04 (s)
β-D-glucosea 3.91 (dd), 3.73 (d), 3.48 (m)
Glycerola 3.78 (m), 3.66 (dd), 3.64 (dd), 3.56 (dd)
3-Methyl-histidinea 3.7 (s)
Taurine 3.42 (t)a 3.42 (t), 3.25 (t)
Scyllo-inositola 3.36 (s)
Cholinea 3.21 (s)
Non-assigned 3.13 (s), 4.04 (d)
Lipids (C = C-CH2-C = C) 2.76 (m)
Glutaminea 2.46 (m), 2.14 (m)
Succinatea 2.41 (s)
Glutamatea 2.36 (dt), 2.04 (m)
3-Hydroxybutyratea 2.31 (m), 1.2 (d)
Lipids (CH2-CO) 2.26 (m)
N-acetylglutaminea 2.02 (s)
Acetatea 1.92 (s)
Lipids (C[H2]-CH2-CO) 1.58 (m)
Alanine 1.48 (d)
Lipids ((−CH2-)n) 1.27 (m)
Valine 1.04 (d), 0.99 (d)
Isoleucinea 1.01 (d)
Leucine 0.96 (dd)
Lipids (CH3) 0.89 (m)
aCompounds that were statistically significant (P < 0.05) between at least a
congenic strain and BN. Patterns of significant differential regulation of these
metabolites in the relevant congenic strains and contributing chromosomal
regions are shown in Fig. 2
S singlet, d doublet, t triplet, m multiplet, dd doublet of doublet, dt doublet
of triplet
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Mapping of eQTL genes and mQTL metabolites onto
metabolic networks
The identification of candidate genes remains difficult be-
cause the size of the genomic blocks prevents us from ap-
plying a classic GWAS “one-SNP-one-gene-at-a-time”
approach. A systems biology approach is thus required to
take into account the fact that each genomic block influ-
ences multiple genes and metabotypes in a coordinated
fashion, which can prove helpful to identify candidate
genes relevant to diabetes and obesity. We have therefore
developed a systems genetics approach stitching together
genetically determined gene expression and metabolic
profiles in a tissue-specific network to rank and prioritize
the validation of candidate genes for adiposity and glucose
homeostasis using cell-based assays.
We built an association network summarizing all signifi-
cant associations between genomic blocks and metabolites
derived from mQTL mapping (BH adjusted P < 0.05) and
A C
B
Fig. 2 Adipose tissue metabotyping of congenic strains and haplotype-based metabotype mapping. 1H NMR spectra obtained at 600 MHz from adipose
tissue extracts of the congenic strains and the BN controls (a) were used to map significant correlation networks (P< 0.05) between strains and metabolites
in order to attach strain specific metabolite patterns (b) and identify chromosomal regions likely to contain GK variants responsible for variations in
metabolite abundance (c) based on a barcode-type scoring for presence or absence of GK haplotypes. Blue bars represent the GK genomic segments
of chromosome 1 of each congenic introgressed onto the genetic background of the BN strain. Genomic regions (R01–R16) were defined by coding
the presence (1) or absence (0) of GK genotypes. Red squares indicate increased metabolite abundance and green squares increased metabolite level
for each congenic strain and genomic region. Details of GK chromosomal regions introgressed in each congenic are given in Table 1. Sample
numbers for each strain: BN (n = 5), 1cons (n = 4), 1b (n = 6), 1d (n = 4), 1f (n = 4), 1h (n = 4), 1k (n = 4), 1o (n = 6), 1p (n = 4), 1q (n = 5), 1t
(n = 5), 1u (n = 6), 1v (n = 5)
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genes derived from eQTL mapping (Fig. 4a). To systemat-
ically search for the mechanistic links between variations
in metabolite abundance and gene expression, we mapped
significant eQTL-responsive genes (39 genes encoding 73
reactions) and mQTL-responsive metabolites (20) onto
metabolic pathways (Fig. 4b). Objective biological relation-
ships between significant changes in gene expression and
metabolite abundance were inferred following mapping of
genes and metabolites to KEGG pathways and computa-
tional analysis of shortest paths between eQTL-associated
genes and mQTL-associated metabolites across the meta-
bolic pathways. Applying a shortest path length threshold
of 1 (spl ≤1), we identified pairs of candidate genes and
metabolites that are directly mechanistically related (i.e.,
the gene codes for an enzyme which directly catalyzes the
reaction involving its paired metabolite; Fig. 4c; Additional
file 3: Table S4). For instance, our network topology
analysis showed direct connection between haplotype-
associated gene G6pc3, encoding glucose-6-phosphatase,
and glucose in chromosomal region 2. Glucose was also
directly connected to Galm, encoding galactose mutaro-
tase (aldose 1-epimerase). Likewise, we identified direct
reactions between Asns, encoding asparagine synthetase
(glutamine-hydrolyzing), and glutamine. To test whether
the distance between the 73 reactions and 20 metabolites
obtained from eQTL and mQTL mapping was signifi-
cantly shorter, we permutation-tested our network under
the null hypothesis: using random lists of 73 reactions and
20 metabolites for each of the 10,000 permutations and
derived shortest paths. The average shortest path length of
the original eQTL–mQTL directed network was 6.54
reactions, which was significantly shorter than the average
shortest path length (obtained for 10,000 undirected
random networks; Fig. 4d).
Fig. 3 Genetic mapping of genome-wide gene expression in the adipose tissue of BN.GK congenic rats derived for chromosome 1 loci. Quantita-
tive trait locus (QTL) mapping was applied to define regions of chromosome 1 showing evidence of statistically significant (LOD >5) linkage with
changes in the transcription of genes localized in genomic regions defined by GK haplotypes (putative cis-acting eQTL effects) or outside the re-
gions (trans-acting eQTL effects). Details of the congenic strains and congenic-defined regions are given in Table 1 and associated transcripts in
Additional file 3: Table S4. The localization of genes regulated in trans is indicated in parentheses
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Through mapping eQTL-responsive genes and
mQTL-responsive metabolites onto the adipose tissue
metabolic network and analyzing its topology, we identi-
fied coordinated regulation of gene transcription and
metabolite abundance in the adipose tissue which may
account for differences in the pathophysiological pheno-
types observed in these congenic strains. We therefore
sought to validate by cell-based assays the relevance of
the Asns and Galm genes predicted by our systems
genetics approach.
Experimental assessment of Asns and Galm function in
vitro
To exemplify the relevance of our network integrating
eQTL-responsive genes and mQTL-responsive metabo-
lites in adipose tissue to prioritize biological validation,
we selected two genes highlighted by our topological
analysis: Asns and Galm. Since we had previously identi-
fied physiological QTLs mapping to chromosome 1 in
the GK rat for adiposity and insulin secretion [9, 11, 14],
we developed a system of shRNA-based expression
knock-down for these genes in 3T3-L1 cells, which are
often used to test cellular phenotypes related to diabetes
(insulin-stimulated glucose uptake) and obesity (lipid ac-
cumulation through oil red-O straining) [24, 25, 27, 48].
Treatment with shRNA targeting Asns and Galm re-
sulted in a 50 % reduction in abundance of the respect-
ive transcripts (Fig. 5a, b). The aspecific shRNA had no
effect on lipid accumulation, a proxy measure of adipo-
cyte differentiation, assessed by oil Red-O staining
(Fig. 5c). Lipid accumulation was significantly hampered
by Asns knockdown, whereas it was unchanged for Galm
knockdown (Fig. 5c). Insulin induced a significant stimu-
lation of glucose transport in both control cells and cells
Fig. 4 Network topological analysis of genetically regulated transcripts and metabotypes. a Summary of adipose transcripts and metabotypes
associated with genomic regions using joint eQTL and mQTL mapping. b Mapping of mQTL-responsive metabolites and eQTL-responsive genes on
an adipose-specific metabolic network. c Biologically relevant relationships between mQTL-responsive metabolites and eQTL-responsive transcripts
highlighted by ranking of shortest path lengths across the metabolic network between gene–metabolite pairs (Additional file 3: Table S5). d Null
distribution of average shortest path lengths obtained after 10,000 permutations consisting of a random selection of 20 metabolites and 73 reactions.
The Asns enzyme has two catalytic sites for two reactions, which are identified as Asns-A and Asns-B in this figure
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transfected with aspecific shRNA (Fig. 5d). This effect
was abolished in Galm-deficient cells, thus demonstrat-
ing the involvement of Galm in the regulation of insulin
signaling. The validation of the role of genes directly
impacting lipid accumulation and glucose uptake in adi-
pocytes identified in adipose tissue in a context of obes-
ity and diabetes illustrates the efficiency of our approach
based on the topology of the metabolic network.
Discussion
Here we report the joint genome mapping of transcripts
and metabolites in adipose tissue extracts using a novel
network-based integration of several -omics dimensions
(genome, transcriptome, and metabolome) to prioritize
mechanistic investigations in adipocyte biology in a con-
text of metabolic syndrome.
Our approach can be summarized as follows. First, we
used a rat congenic panel to study glucose homeostasis and
adiposity whilst limiting epistatic interactions. Second, we
profiled the adipose tissue metabolome and transcriptome
to identify loci regulating metabolism through differential
expression and complex eQTL and mQTL patterns. Third,
to tackle the complexity of these genetically determined co-
regulation patterns between transcripts and metabolites, we
mapped underlying eQTL-responsive genes and mQTL-
responsive metabolites onto metabolic networks and mini-
mized the search space through topological analysis within
those networks, which highlighted mechanistically relevant
pairs of candidate genes and metabolites. Fourth, using
shortest path lengths across the metabolic network, we pri-
oritized genes for mechanistic investigation by gene silen-
cing and uncovered novel roles for Asns and Galm in
adipocyte biology, thus validating the pertinence of our net-
work topology analysis.
This systems genetics approach provides insights into
possible coordinated mechanisms impacted by distinct
series of blocks of genetic polymorphisms in well-
defined genomic regions in congenic strains, as well as
strain-specific phenotypic patterns. The overall intercon-
nectedness of the association patterns between genomic
blocks and metabolites illustrates the complex genetic
architecture of metabolic regulation (Fig. 6). In
Fig. 5 Functional assessment of in vitro shRNA-mediated inhibition of Galm and Asns expression in 3T3-L1 adipocytes. a Asns mRNA expression
levels in anti-Asns shRNA-treated cells expressed as a percentage of control 3T3-L1 cells. b Galm mRNA expression levels in anti-Galm shRNA-treated
cells expressed as a percentage of control 3T3-L1 cells. c Intracellular lipid content of differentiated 3T3-L1 cells was measured by absorbance at
590 nm after Oil Red-O staining. d Glucose uptake was evaluated by measurement of radiolabeled 2-deoxyglucose present in 3T3-L1 cells following
insulin stimulation and normalized to protein level. Shown data represent means ± standard error of the mean. Mann–Whitney tests were performed:
*P < 0.05, **P < 0.01, and ***P < 0.001 significantly different to control; and +++P < 0.001 significantly different to Galm-deficient cells
Dumas et al. Genome Medicine  (2016) 8:101 Page 11 of 15
particular, we identified coordinated changes in the
regulation of metabolite abundance (D-glucose, L-
glutamine) underpinned by trans-mediated expression of
two genes (Galm and Asns) (Fig. 6) and uncovered a
novel role for these genes in adipocyte function, which
may have repercussions on pathophysiological
phenotypes.
Our experimental approach in congenic strains allowed
the dissection of the biological consequences of overlap-
ping series of contiguous, localized GK genetic polymor-
phisms, thus limiting gene × gene interactions (epistatic
effects) to interactions between homozygous GK variants
present in the same genomic blocks. Chromosome substi-
tution strains also demonstrated the impact of epistatic in-
teractions on the detection and significance of genetic
associations [9, 29]. We show that, even in the simplified
context of congenic series, the regulation of adipose tissue
metabolism involves different combinations of metabolites
(i.e., specific metabotypes), thus providing experimental
evidence for the strong capacity of organ metabolism to
adapt to subtle genetic changes.
Such complexity of the metabolic regulation in the con-
genic panel was illustrated by strain-specific changes in
metabolite abundance in adipose tissue, which may ac-
count for phenotypes discriminating GK and BN rats, in-
cluding primarily glucose tolerance and adiposity [9].
Genome mapping of these effects indicate that GK genetic
polymorphisms in several regions of rat chromosome 1
independently affect phosphatidylinositol signaling and
glucose sensing and metabolism, suggesting functional re-
dundancy of genes to ensure maintenance of essential phe-
notypes [35]. Prime examples are significant associations of
GK haplotypes with myo-inositol (region 15) and scyllo-in-
ositol (regions 2 and 6), which are stereoisomers of inositol,
as well as with glucose and L-glutamine (regions 2 and 6)
(Fig. 6). Inositol derivatives regulate insulin signaling in
humans [37] and their conversion is reduced in insulin-
sensitive tissues in the GK rat [38]. Chronic myo-inositol
treatment results in improved glucose homeostasis and
decreased adipocyte volume [41]. Glutamine is a TCA
cycle-replenishing substrate and its analogues regulate in-
sulin sensitivity in cultured adipocytes by preventing the
desensitization of the glucose transport system [42].
Transcriptome data in the congenic strains provided pos-
sible explanations for changes in metabolite regulation,
when the genetic control of metabolites and transcripts en-
coding biologically relevant proteins co-localizes in the
same genomic region. We were able to map to the same
regions of chromosome 1 the genetic control of the
abundance of inositol compounds and transcripts function-
ally relevant to inositol metabolism, including phos-
phatidylinositol glycan anchor biosynthesis class S (Pigs;
LOD= 7.42), inositol polyphosphate phosphatase-like 1
(Inppl1; LOD= 8.04), phosphoinositide-3-kinase, catalytic
subunit type 2 alpha (Pik3c2a; LOD= 5.26), phos-
phatidylinositol 4-kinase type 2 alpha (Pi4k2a; LOD= 9.87),
and inositol-3-phosphate synthase 1 (Isyna1; LOD= 5.73),
which plays a critical role in myo-inositol biosynthesis. Fur-
thermore, association with the transcript encoding protein
phosphatase 2, regulatory subunit B' beta (Ppp2r5b; LOD=
6.34), regulated by Pik3c2a, supports the proposed role of
defective regulation of serine/threonine protein phospha-
tases on insulin resistance in GK adipocytes [43].
Integrative analysis of multi-level -omic datasets in
QTL mapping contexts remains a challenge [39], which
has been best addressed in segregating populations in
yeast [44] and mice [45] through the application of net-
work biology tools. Through search space minimization
within metabolic networks, we designed our metabolic
network topology analysis to highlight direct coordi-
nated functional relationships between genetically deter-
mined transcripts and metabolites and to prioritize them
Fig. 6 Illustration of network-based mapping of eQTL and mQTL signals. Synthetic functional map illustrating biological connections between
genomic regions R02 and R06 of chromosome 1 and differential regulation of transcripts and metabolites
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for experimental validation. This approach is particularly
relevant compared to recent advances in the field. For
instance, MetaboNetworks [47] computes the minimal
network interconnecting a metabolite list but ignores
gene lists. IMPaLA [49] integrates gene and metabolite
lists to perform over-enrichment analyses whilst Ambi-
ent [50] agnostically identifies modules from metabolite
and gene lists in the absence of arbitrarily defined path-
way boundaries. These approaches can be applied to
eQTL-associated genes and mQTL-associated metabo-
lites but do not specifically rely on minimization of the
search space within the network.
Through minimization of shortest path lengths between
candidate eQTL genes and associated mQTL metabolites,
we successfully prioritized and validated the mechanistic
relevance of pairs of transcripts and metabolites, such as L-
glutamine and asparagine synthetase (glutamine-hydrolyz-
ing) (Asns) in region 6 of chromosome 1 corresponding to
the QTL linked to adiposity in the GK× BN F2 cross [9]
(Fig. 1c) or D-glucose and galactose mutarotase (aldose 1-
epimerase; Galm) in region 2. Loci in these regions
accounted for trans-mediated genetic control of transcripts
for Asns (LOD= 5.70) and Galm (LOD= 5.34). ASNS con-
verts glutamate and asparagine into glutamine and aspar-
tate and GALM catalyses the interconversion of the two
glucose anomers. We were able to demonstrate the roles of
these genes in vitro in 3T3-L1 cells in cellular differenti-
ation (Asns) and glucose uptake (Galm), providing new in-
sights into their function in (pre)adipocyte physiology.
Results from functional genomic analyses in BN.GK
congenics illustrate the molecular consequences of natur-
ally occurring DNA polymorphisms originally selected in
the GK strain for their role in the regulation of glucose
homeostasis [51]. The >175-Mb GK genomic region in
the main congenic strain (1cns) contains over 362,300
DNA variants when compared to BN, including 264 non-
synonymous coding variants and exonic deletions [55],
which were dissected out in shorter haplotypes (down to
1 Mb) in congenic sub-strains. A report of polymorphisms
in Inppl1 in the GK affecting insulin sensitivity [56] is con-
sistent with our finding of disrupted regulation of metabo-
lites involved in phosphatidylinositol signaling in adipose
tissue in congenics. Furthermore, analysis of genome se-
quence data in 27 inbred rat strains showed that the pro-
moter region of Galm contains a series of DNA variants
unique to the GK [55], suggesting that they could be etio-
logically relevant to glucose intolerance and adiposity in
the GK strain.
Conclusions
We developed a novel network-based systems genetics [59]
framework for joint mQTL and eQTL analyses of meta-
bolic and gene expression profiles in adipose tissue of a
series of rat congenic strains to dissect metabolic
regulations and identified underlying physical and func-
tional links between significant genes and metabolites, best
exemplified by the novel biological roles we describe for
Galm and Asns in adipocytes. Our metabolic network top-
ology analysis approach integrates haplotype-specific co-
regulated metabolites and gene transcripts, thus providing
crucial information for functional annotation of genomes
and for deciphering disease-associated molecular
mechanisms.
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